Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Achenbach

Showing results (21-30 of 108) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|February 23, 2023
Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotypeSara Puente-Marin, Fabrícia Dietrich, Peter Achenbach, et al.
The Journal of Clinical Investigation|August 18, 2004
Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetesPeter Achenbach, Kerstin Koczwara, Annette Knopff, et al.
Diabetologia|November 21, 2014
Progression from single to multiple islet autoantibodies often occurs soon after seroconversion: implications for early screeningRuth Chmiel, Eleni Z Giannopoulou, Christiane Winkler, et al.
Frontiers in Immunology|November 9, 2020
Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes PatientsRosaura Casas, Fabrícia Dietrich, Hugo Barcenilla, et al.
Diabetes/Metabolism Research and Reviews|October 6, 2021
Immune response differs between intralymphatic or subcutaneous administration of GAD-alum in individuals with recent onset type 1 diabetesFabrícia Dietrich, Hugo Barcenilla, Beatriz Tavira, et al.
The Lancet. Diabetes & Endocrinology|March 30, 2026
Prevalence of early-stage type 1 diabetes in young adults: a population-based cohort studyMarie Standl, Marlon Scholz, Elisabeth Thiering, et al.
Diabetes|February 28, 2007
GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetesAnja Mayr, Michael Schlosser, Natalie Grober, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 21, 2022
Imputing Longitudinal Growth Data in International Pediatric Studies: Does CDC Reference Suffice?Zhiguo Li, Jorma Toppari, Markus Lundgren, et al.
Journal of Autoimmunity|March 8, 2011
Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young childrenAnette-G Ziegler, Maren Pflueger, Christiane Winkler, et al.
Diabetes Care|June 20, 2019
Age, HLA, and Sex Define a Marked Risk of Organ-Specific Autoimmunity in First-Degree Relatives of Patients With Type 1 DiabetesChristiane Winkler, Manja Jolink, Annette Knopff, et al.
Pageof 11

Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|February 23, 2023
Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotypeSara Puente-Marin, Fabrícia Dietrich, Peter Achenbach, et al.
The Journal of Clinical Investigation|August 18, 2004
Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetesPeter Achenbach, Kerstin Koczwara, Annette Knopff, et al.
Diabetologia|November 21, 2014
Progression from single to multiple islet autoantibodies often occurs soon after seroconversion: implications for early screeningRuth Chmiel, Eleni Z Giannopoulou, Christiane Winkler, et al.
Frontiers in Immunology|November 9, 2020
Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes PatientsRosaura Casas, Fabrícia Dietrich, Hugo Barcenilla, et al.
Diabetes/Metabolism Research and Reviews|October 6, 2021
Immune response differs between intralymphatic or subcutaneous administration of GAD-alum in individuals with recent onset type 1 diabetesFabrícia Dietrich, Hugo Barcenilla, Beatriz Tavira, et al.
The Lancet. Diabetes & Endocrinology|March 30, 2026
Prevalence of early-stage type 1 diabetes in young adults: a population-based cohort studyMarie Standl, Marlon Scholz, Elisabeth Thiering, et al.
Diabetes|February 28, 2007
GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetesAnja Mayr, Michael Schlosser, Natalie Grober, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 21, 2022
Imputing Longitudinal Growth Data in International Pediatric Studies: Does CDC Reference Suffice?Zhiguo Li, Jorma Toppari, Markus Lundgren, et al.
Journal of Autoimmunity|March 8, 2011
Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young childrenAnette-G Ziegler, Maren Pflueger, Christiane Winkler, et al.
Diabetes Care|June 20, 2019
Age, HLA, and Sex Define a Marked Risk of Organ-Specific Autoimmunity in First-Degree Relatives of Patients With Type 1 DiabetesChristiane Winkler, Manja Jolink, Annette Knopff, et al.
Pageof 11